CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 205 filers reported holding CHEMOCENTRYX INC in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $121,100,000 | +9116.1% | 3,000 | -91.7% | 1.26% | +326.7% |
Q1 2022 | $1,314,000 | 0.0% | 36,100 | 0.0% | 0.30% | +1.0% |
Q4 2021 | $1,314,000 | -81.6% | 36,100 | -61.7% | 0.29% | -83.0% |
Q3 2021 | $7,131,000 | +76.4% | 94,300 | +62.3% | 1.72% | +61.2% |
Q2 2021 | $4,043,000 | -72.6% | 58,100 | -79.9% | 1.07% | -72.7% |
Q1 2021 | $14,779,000 | -6.4% | 288,600 | +12.9% | 3.91% | -9.3% |
Q4 2020 | $15,783,000 | +1121.6% | 255,600 | +983.1% | 4.31% | +933.8% |
Q3 2020 | $1,292,000 | -87.7% | 23,600 | -87.7% | 0.42% | -88.0% |
Q2 2020 | $10,465,000 | +37.2% | 191,600 | +0.8% | 3.48% | +0.0% |
Q1 2020 | $7,629,000 | – | 190,000 | – | 3.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
Birchview Capital, LP | 25,000 | $428,000 | 0.29% |